Gurgaon Samachar

Alopecia Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight

 Breaking News
  • No posts were found

Alopecia Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight

April 30
15:30 2020

DelveInsight has launched a new report on Cold Agglutinin Disease Market Insights, Epidemiology and Market Forecast-2030

DelveInsight’s Alopecia  Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Alopecia  epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Hair loss, also knownas alopecia orbaldness, refers toa loss of hair from part of thehead or body.Typically,atleasttheheadisinvolved,andtheseverityofhairlosscanvaryfromasmall areatotheentirebody. About one-third of women experience hair loss at some time in their lives; among postmenopausal women, as many as two-thirds suffer hair thinning or bald spots. Hairloss in women often has a greater impact than hair loss does on men, because it is less socially acceptableforthem.Alopeciacanseverelyaffectawoman’semotionalwell-beingandquality oflif.

                                                      

 

Click Here- Free sample page

Epidemiology

The Alopecia epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Alopecia  epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Alopecia epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Report key facts-

1. As per the study by Severi et al. titled, “Androgenetic alopecia in men aged 40–69 years: prevalence and risk factors,” the prevalence of vertex and full androgenic alopecia increased with age from approximately 30% (age 40–55 years) to 50% (age65–69years.

2. According to the National Alopecia Areata Foundation,alopeciaareataaffectsasmanyas6.8 million people in the US with a lifetime risk of 2.1%. People of all ages, both sexes and all ethnic groups can develop alopecia are ata.

 3. As per the article by Whiting et al. titled, “Cicatricial alopecia: clinicopathological findings and treatment,” the prevalence of cicatricial alopeciaintheUSis7%.

Some of key companies are working on this disease which are given below-

1. Merck Pharma Co.

2. Johnson & Johnson Co. 

3. Samumed

Name of drugs covered which are given below-

1. Propecia (finasteride)

2. Rogaine (Minoxidil)

3.  SM04554

Table of content

1. Key Insights

2. Executive Summary of Alopecia

3. Competitive Intelligence Analysis for Alopecia

4. Alopecia: Market Overview at a Glance

4.1. Alopecia Total Market Share (%) Distribution in 2017

4.2. Alopecia Total Market Share (%) Distribution in 2030

5. Alopecia: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Patient Journey

7. Alopecia Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Alopecia Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Alopecia Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Alopecia Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Alopecia Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Alopecia Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Alopecia Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Alopecia Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Alopecia Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Alopecia Treatment and Management

8.2. Alopecia Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Alopecia Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

13. Alopecia: Seven Major Market Analysis

13.1. Key Findings

13.2. Alopecia Market Size in 7MM

13.3. Alopecia Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Alopecia Total Market Size in the United States

15.1.2. Alopecia Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Alopecia Total Market Size in Germany

15.3.2. Alopecia Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Alopecia Total Market Size in France

15.4.2. Alopecia Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Alopecia Total Market Size in Italy

15.5.2. Alopecia Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Alopecia Total Market Size in Spain

15.6.2. Alopecia Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Alopecia Total Market Size in the United Kingdom

15.7.2. Alopecia Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Alopecia Total Market Size in Japan

15.8.3. Alopecia Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Alopecia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Why should you buy this report?

  • The Alopecia Epidemiology report will allow the user to –
  • Develop business strategies by understanding the trends shaping and driving the global Alopecia  market
  • Quantify patient populations in the global Alopecia market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Alopecia  therapeutics in each of the markets covered
  • Understand the magnitude of Alopecia population by its epidemiology
  • The Alopecia  Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 Related Reports-

Alopecia – Epidemiology Forecast to 2030

 

Alopecia – Pipeline Insights, 2020

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/haridwartoday/gurgaon-samachar.com/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share